If you have an account please sign in to continue
Dialog Box
Kickstart 2021 with a commitment to saving women’s lives. Become a founding member of The Lab this Ovarian Cancer Awareness Month.
See how the OCRF community has stepped up in the name of ovarian cancer research and awareness in our annual report
Learn more about the state of ovarian cancer in Australia, and how you can help advocate for greater research funding.
Discover who we are, what we do and how your support can help change the statistics for Australian women.
What we do
Learn about the silent killer that claims another Australian life every eight hours.
Learn the facts
Through innovative ovarian cancer research, we aim to improve the lives of women with ovarian cancer today and increase survival rates in the future.
Discover our vision
Research relies on your support. Find out how you can fundraise on our behalf, show your support to our partners, or use your voice to spark action.
Find out more
"I want my daughter and her friends to be able to grow up and have a test for ovarian cancer as part of their regular health check-up. I don’t want them to fear this. It’s not going to save my life, but it might just save hers or one of her friends."
OCRF Ambassador Kel Pittman
$9,050 raised so far
$1,820 raised so far
$610 raised so far
Research
Ovarian cancer researcher Dr Maree Bilandzic discusses the desperate need for greater funding security for ovarian cancer researchers in order to maintain progress that will save Australian women's lives.
News
Contribute to the OCRF submission to put ovarian cancer drug Niraparib on the Pharmaceutical Benefits Scheme (PBS) in Australia.
Blog
The State of the Nation in ovarian cancer report revealed 3 key goals to see a stepped change in ovarian cancer survival. The first goal is to see a 50% survival rate across Australia through the establishment and implementation of four key priorities.
The Medical Research Future Fund (MRFF) announced in December 2020, a $25 million funding round available for early detection research into low-survival cancers, including ovarian cancer, following the State of the Nation report.